The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Serial monitoring of imatinib pharmacokinetics (PK) in perioperative imatinib treatment in patients (pts) with gastrointestinal stromal tumors (GISTs): Results from the multinational phase II trial.
 
Changhoon Yoo
No Relationships to Disclose
 
Min-Hee Ryu
No Relationships to Disclose
 
Yukinori Kurokawa
Honoraria - Chugai Pharma; Lilly Japan; Novartis; Pfizer; Taiho Pharmaceutical; Yakult Honsha
 
Han-Kwang Yang
No Relationships to Disclose
 
Toshirou Nishida
No Relationships to Disclose
 
Seong-Ho Kong
No Relationships to Disclose
 
Toshimasa Tsujinaka
No Relationships to Disclose
 
Kyung Hee Lee
No Relationships to Disclose
 
Hiroshi Yabusaki
No Relationships to Disclose
 
Hong-Suk Song
No Relationships to Disclose
 
Hiromitsu Akabane
No Relationships to Disclose
 
Seock-Ah Im
No Relationships to Disclose
 
Kazuaki Tanabe
No Relationships to Disclose
 
Hye Jin Kang
No Relationships to Disclose
 
Takashi Nomura
No Relationships to Disclose
 
Byung Wook Kang
No Relationships to Disclose
 
Tetsu Nakamura
No Relationships to Disclose
 
Masaaki Okubo
No Relationships to Disclose
 
Hirokazu Taniguchi
No Relationships to Disclose
 
Yoon-Koo Kang
Consulting or Advisory Role - Lilly/ImClone; Novartis; Ono Pharmaceutical; Roche/Genentech; Taiho Pharmaceutical
Research Funding - Bayer; Novartis; Roche/Genentech